Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world evidence of cisplatin versus carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicenter analysis.
Dechaphunkul A, Danchaivijitr P, Jiratrachu R, Dechaphunkul T, Sookthon C, Jiarpinitnun C, Paoin C, Setakornnukul J, Suktitipat B, Pattaranutaporn P, Ngamphaiboon N. Dechaphunkul A, et al. Among authors: jiarpinitnun c. Asia Pac J Clin Oncol. 2023 Feb;19(1):51-61. doi: 10.1111/ajco.13668. Epub 2022 Apr 8. Asia Pac J Clin Oncol. 2023. PMID: 35394108
Long Term Outcomes of Preoperative versus Postoperative Concurrent Chemoradiation for Locally Advanced Rectal Cancer: Experience from Ramathibodi Medical School in Thailand.
Darunikorn P, Puataweepong P, Dhanachai M, Dangprasert S, Swangsilpa T, Sitathanee C, Jiarpinitnun C, Pattaranutaporn P, Boonyawan K, Chansriwong P. Darunikorn P, et al. Among authors: jiarpinitnun c. Asian Pac J Cancer Prev. 2015;16(16):7315-9. doi: 10.7314/apjcp.2015.16.16.7315. Asian Pac J Cancer Prev. 2015. PMID: 26514530 Free article.
Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers.
Tamtai A, Jiarpinitnun C, Hiranyatheb P, Unwanatham N, Sirachainun E, Supsamutchai C, Pattaranutaporn P, Ngamphaiboon N. Tamtai A, et al. Among authors: jiarpinitnun c. Med Oncol. 2017 Sep;34(9):157. doi: 10.1007/s12032-017-1017-z. Epub 2017 Aug 7. Med Oncol. 2017. PMID: 28785986
Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand.
Ngamphaiboon N, Dechaphunkul A, Setakornnukul J, Dechaphunkul T, Jiratrachu R, Suktitipat B, Jiarpinitnun C, Pattaranutaporn P, Danchaivijitr P. Ngamphaiboon N, et al. Among authors: jiarpinitnun c. BMC Cancer. 2020 Jun 3;20(1):518. doi: 10.1186/s12885-020-07024-8. BMC Cancer. 2020. PMID: 32493288 Free PMC article.
Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
Corry J, Ng WT, Moore A, Choi HCW, Le Q, Holmes S, Munandar A, Wang S, Camacho A, Setakornnukul J, Jiarpinitnun C, Hiep PN, Laskar SG, Benjaafar N, Faheem M, Jin F, Ammar CNB, Ali R, Boualga K, Abdelwahab S, Sommat K, Tao Y, O'Sullivan B, Lee N, Zubizaretta E, Prajogi B, Hopkins K, Rosenblatt E, Lee AWM. Corry J, et al. Among authors: jiarpinitnun c. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1227-1236. doi: 10.1016/j.ijrobp.2021.08.013. Epub 2021 Aug 19. Int J Radiat Oncol Biol Phys. 2021. PMID: 34418466
28 results